Investigating how a specific RNA affects kidney injury after reduced blood flow.
The regulation and function of long non coding RNA in ischemic AKI: Role of GSTM3P1
This study is looking at how a certain molecule in our cells might help protect the kidneys from damage during events like heart attacks or major surgeries, with the goal of finding better ways to help patients who experience acute kidney injury.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-10747905 on NIH RePORTER |
What this research studies
This research focuses on understanding acute kidney injury (AKI), particularly how it can occur due to reduced blood flow, such as during heart attacks or major surgeries. The study aims to explore the role of a specific long non-coding RNA, GSTM3P1, in regulating kidney cell death. By examining how GSTM3P1 interacts with protective microRNAs, the researchers hope to uncover new therapeutic strategies to improve survival rates for patients suffering from AKI. This investigation involves both laboratory experiments and analysis of cellular pathways related to kidney health.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced acute kidney injury due to ischemia or related cardiovascular events.
Not a fit: Patients with chronic kidney disease not related to acute ischemic events may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve survival rates and outcomes for patients with acute kidney injury.
How similar studies have performed: Previous research has shown that targeting long non-coding RNAs can be effective in managing kidney diseases, suggesting a promising avenue for this investigation.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Wei, Qingqing — Augusta University
- Study coordinator: Wei, Qingqing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.